Marie Curie Actions

Study asks if mistaken antibodies led research down 20-year dead end

3 July 2017 | By Niamh Marriott (Drug Target Review)

For nearly two decades researchers have sought a way to target an oestrogen receptor in the hope they could improve breast cancer survival, but an article contends that the effort may never pan out.